Guaifenesin and Codeine Oral Solution or Syrup |
Brontex Liquid; Cheracol Cough Syrup; Diabetic Tussin C; Gani-Tuss NR; Guaituss AC Syrup; Halotussin AC; Mytussin AC Cough Syrup; Robafen AC Cough Syrup; Robitussin AC Syrup; Romilar AC Syrup; Tussi-Organidin NR; Tussi-Organidin-S NR |
Clinical Trial: Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat
This study has been suspended.
Purpose
RATIONALE: Glutamine may be effective in decreasing side effects, such as inflammation of the mouth and throat, caused by radiation therapy. The effectiveness of glutamine for mucositis is not yet known.
PURPOSE: Randomizedphase III trial to determine the effectiveness of glutamine in treating patients who develop mucositis following radiation therapy for newly diagnosed cancer of the mouth or throat.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| lip and oral cavity cancer oral complications of chemotherapy and head and neck radiation Oropharyngeal Cancer Pain radiation toxicity | Drug: glutamine Procedure: complications of therapy assessment/management Procedure: pain therapy Procedure: radiation therapy Procedure: radioprotection Procedure: supportive care/therapy | Phase III |
MedlinePlus related topics: Head and Neck Cancer; Oral Cancer; Pain
Study Type: Interventional
Study Design: Treatment
Official Title: Phase III Randomized Study of L-Glutamine For Radiotherapy-Induced Oral Mucositis in Patients With Newly Diagnosed, Previously Untreated Squamous Cell Cancer of the Oral Cavity or Oropharynx Receiving High-Dose Radiotherapy
OBJECTIVES:
- Compare the efficacy of L-glutamine vs placebo, in terms of maximum mucositis toxic effects and worst reported mouth pain during and after high-dose radiotherapy, in patients with newly diagnosed, previously untreated squamous cell cancer of the oral cavity or oropharynx.
- Compare the duration of severe mucositis in patients treated with these regimens.
- Compare the radiotherapy delay in patients treated with these regimens.
- Compare weight loss in patients treated with these regimens.
- Compare the toxic effects of these two regimens in these patients.
- Compare patient-reported mouth pain success rate in patients treated with these regimens.
- Determine the compliance of patients treated with this drug regimen.
OUTLINE: This is a randomized, double-blind, placebo-controlled, multicenter study. Patients are stratified according to concurrent cisplatin or carboplatin (yes vs no), concurrent fluorouracil (yes vs no), and presence of feeding tube (yes vs no). Patients are randomized to 1 of 2 treatment arms.
- Arm I: Beginning 4 to 7 days prior to radiotherapy, patients receive oral L-glutamine 3 times daily for 60-80 days. Patients receive concurrent high-dose radiotherapy for approximately 6 weeks.
- Arm II: Patients receive oral placebo and high-dose radiotherapy as in arm I. In both arms, treatment continues in the absence of unacceptable toxicity.
Patients are followed for 2 weeks.
PROJECTED ACCRUAL: A total of 158 patients (79 per treatment arm) will be accrued for this study within 2.5 years.
Eligibility
Ages Eligible for Study: 18 Years - 90 Years, Genders Eligible for Study: Both
Criteria
DISEASE CHARACTERISTICS:
- Newly diagnosed, previously untreated squamous cell cancer of the oral cavity or oropharynx (T1-T4, any N, M0)
- Must be scheduled to receive high-dose radiotherapy
- Not concurrently receiving or planning to receive treatment on any other Southwest Oncology Group protocol
PATIENT CHARACTERISTICS: Age:
- 18 to 90
Performance status:
- Zubrod 0-2
Life expectancy:
- Not specified
Hematopoietic:
- Not specified
Hepatic:
- Not specified
Renal:
- Not specified
Other:
- No other malignancy within the past 5 years except adequately treated basal cell or squamous cell skin cancer, carcinoma in situ of the cervix, or stage I or II cancer currently in complete remission
- Not pregnant or nursing
- Fertile patients must use effective contraception
PRIOR CONCURRENT THERAPY: Biologic therapy:
- Not specified
Chemotherapy:
- No prior chemotherapy
- Concurrent cisplatin, carboplatin, or fluorouracil allowed
- No other concurrent chemotherapy during study and for at least 3 weeks after study radiotherapy
Endocrine therapy:
- Not specified
Radiotherapy:
- See Disease Characteristics
Surgery:
- Not specified
Other:
- No concurrent amifostine during and for 2 weeks after study radiotherapy
Location Information
Alabama
MBCCOP - Gulf Coast, Mobile, Alabama, 36607, United States
Arizona
Arizona Cancer Center at University of Arizona Health Sciences Center, Tucson, Arizona, 85724, United States
CCOP - Western Regional, Arizona, Phoenix, Arizona, 85006-2726, United States
Veterans Affairs Medical Center - Phoenix (Carl T. Hayden), Phoenix, Arizona, 85012, United States
Veterans Affairs Medical Center - Tucson, Tucson, Arizona, 85723, United States
Arkansas
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences, Little Rock, Arkansas, 72205, United States
Veterans Affairs Medical Center - Little Rock (McClellan), Little Rock, Arkansas, 72205, United States
California
CCOP - Bay Area Tumor Institute, Oakland, California, 94609-3305, United States
CCOP - Santa Rosa Memorial Hospital, Santa Rosa, California, 95403, United States
Chao Family Comprehensive Cancer Center at University of California Irvine Cancer Center, Orange, California, 92868, United States
City of Hope Comprehensive Cancer Center, Duarte, California, 91010-3000, United States
David Grant Medical Center, Travis Air Force Base, California, 94535, United States
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, 90095-1781, United States
UCSF Comprehensive Cancer Center, San Francisco, California, 94143-0128, United States
University of California Davis Cancer Center, Sacramento, California, 95817, United States
USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, 90033, United States
Veterans Affairs Medical Center - Long Beach, Long Beach, California, 90822, United States
Veterans Affairs Medical Center - West Los Angeles, Los Angeles, California, 90073, United States
Veterans Affairs Outpatient Clinic - Martinez, Martinez, California, 94553, United States
Colorado
University of Colorado Cancer Center at University of Colorado Health Sciences Center, Aurora, Colorado, 80010, United States
Veterans Affairs Medical Center - Denver, Denver, Colorado, 80220, United States
District of Columbia
MBCCOP - Howard University Cancer Center, Washington, District of Columbia, 20060, United States
Florida
Veterans Affairs Medical Center - Tampa (Haley), Tampa, Florida, 33612, United States
Georgia
CCOP - Atlanta Regional, Atlanta, Georgia, 30342-1701, United States
Dwight David Eisenhower Army Medical Center, Fort Gordon, Georgia, 30905-5650, United States
Hawaii
MBCCOP - Hawaii, Honolulu, Hawaii, 96813, United States
Tripler Army Medical Center, Honolulu, Hawaii, 96859-5000, United States
Illinois
Cardinal Bernardin Cancer Center at Loyola University Medical Center, Maywood, Illinois, 60153-5500, United States
CCOP - Central Illinois, Decatur, Illinois, 62526, United States
MBCCOP - University of Illinois at Chicago, Chicago, Illinois, 60612, United States
Veterans Affairs Medical Center - Chicago (Westside Hospital), Chicago, Illinois, 60612, United States
Veterans Affairs Medical Center - Hines (Hines Junior VA Hospital), Hines, Illinois, 60141, United States
Iowa
Genesis Regional Cancer Center at Genesis Medical Center, Davenport, Iowa, 52804, United States
Kansas
CCOP - Wichita, Wichita, Kansas, 67214-3882, United States
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center, Kansas City, Kansas, 66160-7353, United States
Veterans Affairs Medical Center - Wichita, Wichita, Kansas, 67218, United States
Kentucky
Markey Cancer Center at University of Kentucky Chandler Medical Center, Lexington, Kentucky, 40536-0084, United States
Veterans Affairs Medical Center - Lexington, Lexington, Kentucky, 40502-2236, United States
Louisiana
Louisiana State University Health Sciences Center - Shreveport, Shreveport, Louisiana, 71130-3932, United States
MBCCOP - LSU Health Sciences Center, New Orleans, Louisiana, 70112, United States
Tulane Cancer Center at Tulane University Hospital and Clinic, New Orleans, Louisiana, 70112, United States
Veterans Affairs Medical Center - New Orleans, New Orleans, Louisiana, 70112, United States
Veterans Affairs Medical Center - Shreveport, Shreveport, Louisiana, 71101-4295, United States
Massachusetts
Cancer Research Center at Boston Medical Center, Boston, Massachusetts, 02118, United States
Michigan
Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, 48201-1379, United States
CCOP - Beaumont, Royal Oak, Michigan, 48073-6769, United States
CCOP - Grand Rapids, Grand Rapids, Michigan, 49503, United States
CCOP - Michigan Cancer Research Consortium, Ann Arbor, Michigan, 48106, United States
Josephine Ford Cancer Center at Henry Ford Hospital, Detroit, Michigan, 48202, United States
Providence Cancer Institute at Providence Hospital, Southfield, Michigan, 48075, United States
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, 48109-0912, United States
Veterans Affairs Medical Center - Ann Arbor, Ann Arbor, Michigan, 48105, United States
Veterans Affairs Medical Center - Detroit, Detroit, Michigan, 48201-1932, United States
Minnesota
CCOP - Duluth, Duluth, Minnesota, 55805, United States
Mississippi
Keesler Medical Center - Keesler Air Force Base, Keesler AFB, Mississippi, 39534-2576, United States
University of Mississippi Medical Center, Jackson, Mississippi, 39216-4505, United States
Veterans Affairs Medical Center - Jackson, Jackson, Mississippi, 39216, United States
Missouri
CCOP - Cancer Research for the Ozarks, Springfield, Missouri, 65807, United States
CCOP - Kansas City, Kansas City, Missouri, 64131, United States
CCOP - St. Louis-Cape Girardeau, Saint Louis, Missouri, 63141, United States
St. Louis University Hospital Cancer Center, Saint Louis, Missouri, 63110, United States
Montana
CCOP - Montana Cancer Consortium, Billings, Montana, 59101, United States
New Jersey
Veterans Affairs Medical Center - East Orange, East Orange, New Jersey, 07018-1095, United States
New Mexico
MBCCOP - University of New Mexico HSC, Albuquerque, New Mexico, 87131, United States
Veterans Affairs Medical Center - Albuquerque, Albuquerque, New Mexico, 87108-5138, United States
New York
Herbert Irving Comprehensive Cancer Center at Columbia University, New York, New York, 10032, United States
James P. Wilmot Cancer Center at University of Rochester Medical Center, Rochester, New York, 14642, United States
NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York, New York, 10016, United States
North Carolina
CCOP - Southeast Cancer Control Consortium, Winston Salem, North Carolina, 27104-4241, United States
Veterans Affairs Medical Center - Salisbury, Salisbury, North Carolina, 28144, United States
Ohio
Arthur G. James Cancer Hospital - Ohio State University, Columbus, Ohio, 43210-1240, United States
CCOP - Columbus, Columbus, Ohio, 43206, United States
CCOP - Dayton, Dayton, Ohio, 45429, United States
CCOP - Toledo Community Hospital, Toledo, Ohio, 43623-3456, United States
Charles M. Barrett Cancer Center at University Hospital, Cincinnati, Ohio, 45267-0501, United States
Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, 44195-9001, United States
Veterans Affairs Medical Center - Cincinnati, Cincinnati, Ohio, 45220-2288, United States
Veterans Affairs Medical Center - Dayton, Dayton, Ohio, 45428-1002, United States
Oklahoma
Oklahoma University Medical Center, Oklahoma City, Oklahoma, 73104, United States
Oregon
Cancer Institute at Oregon Health and Science University, Portland, Oregon, 97201-3098, United States
CCOP - Columbia River Oncology Program, Portland, Oregon, 97225, United States
Veterans Affairs Medical Center - Portland, Portland, Oregon, 97207, United States
South Carolina
CCOP - Greenville, Greenville, South Carolina, 29615, United States
CCOP - Upstate Carolina, Spartanburg, South Carolina, 29303, United States
Hollings Cancer Center at Medical University of South Carolina, Charleston, South Carolina, 29425, United States
Veterans Affairs Medical Center - Charleston, Charleston, South Carolina, 29401-5799, United States
Tennessee
Danville Radiation Therapy Center, Memphis, Tennessee, 38104, United States
University of Tennessee Cancer Institute, Memphis, Tennessee, 38104, United States
Texas
Brooke Army Medical Center, Fort Sam Houston, Texas, 78234-6200, United States
CCOP - Scott and White Hospital, Temple, Texas, 76508, United States
Harrington Cancer Center, Amarillo, Texas, 79106, United States
University of Texas - MD Anderson Cancer Center, Houston, Texas, 77030-4095, United States
University of Texas Health Science Center at San Antonio, San Antonio, Texas, 78229-3900, United States
University of Texas Medical Branch, Galveston, Texas, 77555-0565, United States
Veterans Affairs Medical Center - Amarillo, Amarillo, Texas, 79106, United States
Veterans Affairs Medical Center - Dallas, Dallas, Texas, 75216, United States
Veterans Affairs Medical Center - Houston, Houston, Texas, 77030, United States
Veterans Affairs Medical Center - San Antonio (Murphy), San Antonio, Texas, 78229, United States
Veterans Affairs Medical Center - Temple, Temple, Texas, 76504, United States
Utah
Huntsman Cancer Institute, Salt Lake City, Utah, 84112-5550, United States
Veterans Affairs Medical Center - Salt Lake City, Salt Lake City, Utah, 84148, United States
Washington
CCOP - Northwest, Tacoma, Washington, 98405-0986, United States
CCOP - Virginia Mason Research Center, Seattle, Washington, 98101, United States
Madigan Army Medical Center, Tacoma, Washington, 98431-5000, United States
Swedish Cancer Institute at Swedish Medical Center - First Hill Campus, Seattle, Washington, 98104, United States
Veterans Affairs Medical Center - Seattle, Seattle, Washington, 98108, United States
Canada, Ontario
Hospital for Sick Children, Toronto, Ontario, M5G 1X8, Canada
V. Suzanne Klimberg, MD, Study Chair, Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
More Information
Clinical trial summary from the National Cancer Institute's PDQ® database
Record last reviewed: September 2004
Last Updated: October 13, 2004
Record first received: December 6, 2000
ClinicalTrials.gov Identifier: NCT00006994
Health Authority: Unspecified
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- Brontex Liquid (Drug Digest)
- Cheracol Cough Syrup (Drug Digest)

Not Signed In -

